1007-3418
2012 Issue 5
Prospective study of the association between fasting glucose concentrations and liver cirrhosis risk
YIN Liang-yu;CHEN Wen;CUI Jian-feng;LIU Bin;YIN Jian;FAN Jin-hu;CHEN Feng;LIU Xin-fu;FU Chun-jing;DAI Xing-bi
YIN Liang-yu;CHEN Wen;CUI Jian-feng;LIU Bin;YIN Jian;FAN Jin-hu;CHEN Feng;LIU Xin-fu;FU Chun-jing;DAI Xing-bi
..............page:381-385
Acetoacetate extract from celastrus orbiculatus thunb inhibits growth of RFP-xenografted human liver carcinoma
WANG Mao-rong;ZHANG Xin;LIU Yan-qing
WANG Mao-rong;ZHANG Xin;LIU Yan-qing
..............page:377-380
Real-time elastography for quantitative assessment of liver fibrosis in a rat model
LIN Sen-hao;MA Jiao-jiao;ZHANG Hui;DING Hong;YU Qing;ZHU Hong-guang;ZENG Wen-jiao;WANG Wen-ping
LIN Sen-hao;MA Jiao-jiao;ZHANG Hui;DING Hong;YU Qing;ZHU Hong-guang;ZENG Wen-jiao;WANG Wen-ping
..............page:386-389
Hepatitis C virus F protein-mediated inhibition of hepatoma cell proliferation
ZHOU Fan;LIU Jiao;CHEN Qing-mei;SHAN Xiao-liang;CHEN Lin-lin;QUAN Hui-qin;TANG Ni
ZHOU Fan;LIU Jiao;CHEN Qing-mei;SHAN Xiao-liang;CHEN Lin-lin;QUAN Hui-qin;TANG Ni
..............page:368-371
Characterisctic of liver pathology in HBeAg-positive and HBeAg-negative chronic hepatitis B patients with mildly elevated ALT
LIU Shun-qing;ZHU Xiao-jun;SUN Xue-hua;LI Man;GAO Yue-qiu
LIU Shun-qing;ZHU Xiao-jun;SUN Xue-hua;LI Man;GAO Yue-qiu
..............page:348-352
Long-term assessment of relapse and associated risk factors in chronic hepatitis C patients treated with interferon and ribavirin
LI Quan-run;ZHANG Chang-jiang;XIONG Yu-lin;ZHU Yan;TAN Zhao-xia;HU Ya-jun;YUAN Jing;WANG Xiao-hong
LI Quan-run;ZHANG Chang-jiang;XIONG Yu-lin;ZHU Yan;TAN Zhao-xia;HU Ya-jun;YUAN Jing;WANG Xiao-hong
..............page:353-356
Therapy for refractory primary biliary cirrhosis
HAN Ying;ZHU Jiang-yi
HAN Ying;ZHU Jiang-yi
..............page:330-332
Efficacy and safety of a protease inhibitor with pegylated interferon and ribavirin in patients with untreated chronic hepatitis C: a meta analysis
YUAN Xue-lan;LI Mao-ying;ZHANG Da-zhi
YUAN Xue-lan;LI Mao-ying;ZHANG Da-zhi
..............page:357-362
A systematic review and meta-analysis of randomized controlled trails : adjuvant interferon therapy for hepatocellular carcinoma
ZHUANG Li-ping;ZENG Xian-tao;MENG Zhi-qiang
ZHUANG Li-ping;ZENG Xian-tao;MENG Zhi-qiang
..............page:363-367
The therapeutic effect of Anluohuaxian capsule combined with adefovir dipivoxil on patients with chronic hepatitis B and influence on hepatic histology
JIANG Yong-fang;MA Jing;HE Bo;LI Nai-ping;TANG Wei;GONG Guo-zhong
JIANG Yong-fang;MA Jing;HE Bo;LI Nai-ping;TANG Wei;GONG Guo-zhong
..............page:344-347
Role of specific T cells in autoimmune hepatitis
ZHAO Yan;LI Yan-li;YAN Hui-ping
ZHAO Yan;LI Yan-li;YAN Hui-ping
..............page:333-335
..............page:321-323
Role of sex hormones in nonalcoholic fatty liver disease pathogenesis
WANG Ya-dong;ZHANG Ying-ze;ZHAO Cai-yan;CAO Wei
WANG Ya-dong;ZHANG Ying-ze;ZHAO Cai-yan;CAO Wei
..............page:398-400
Correlation study of estrogen receptor with peripheral blood cytokines and serum markers in primary biliary cirrhosis patients
WANG Lei;LI Qing-mei;DU Hui-hui;WANG Li-qiong;LIU Yi-bo;ZHANG Wei
WANG Lei;LI Qing-mei;DU Hui-hui;WANG Li-qiong;LIU Yi-bo;ZHANG Wei
..............page:336-339
Clinical and pathological features of autoimmune hepatitis: no significant differences between genders
WANG Qi-xia;MIAO Qi;XIAO Xiao;SHEN Lei;CHEN Xiao-yu;QIU De-kai;MA Xiong
WANG Qi-xia;MIAO Qi;XIAO Xiao;SHEN Lei;CHEN Xiao-yu;QIU De-kai;MA Xiong
..............page:340-343
The expression of NPRL2 protein in hepatocellular carcinoma and its clinical significance
MA Yan-ling;SUN Jian-hai;YAN Fei;LI Li;LIU Li
MA Yan-ling;SUN Jian-hai;YAN Fei;LI Li;LIU Li
..............page:390-391
Diagnosis and management of autoimmune hepatitis with acute presentation
ZHANG Hai-yan;MA Xiong
ZHANG Hai-yan;MA Xiong
..............page:396-397
Dynamic alterations of angiotensin-converting enzyme,angiotensin-(1-7), and insulin-like growth factor binding proten-2 in fibrotic rat liver
ZHANG Ning;SHEN Feng-jun;ZHAO Cai-xia;TANG Jin
ZHANG Ning;SHEN Feng-jun;ZHAO Cai-xia;TANG Jin
..............page:392-394
..............page:323,356,376,385,400
Changes of the serum adiponectin during treatment with peginterferon α-2a and ribavirin for chronic hepatitis C
HUANG Ping;YANG Yong-feng;XIONG Qing-fang;ZHONG Yan-dan
HUANG Ping;YANG Yong-feng;XIONG Qing-fang;ZHONG Yan-dan
..............page:394-395
Differential diagnosis and therapy for autoimmune hepatitis and drug-induced liver injury
MIAO Qi;MA Xiong
MIAO Qi;MA Xiong
..............page:327-329
Recent progress in laboratory diagnosis of autoimmune liver disease
ZHONG Ren-qian;YANG Zai-xing;LIANG Yan;QIN Bao-dong
ZHONG Ren-qian;YANG Zai-xing;LIANG Yan;QIN Bao-dong
..............page:324-326
Biological function explore of protein CCL15 in HCC cell lines
LI Yue-guo;ZHANG Peng
LI Yue-guo;ZHANG Peng
..............page:372-376